Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-21 @ 1:26 PM
Study NCT ID:
NCT02472756
Status:
COMPLETED
Last Update Posted:
2017-08-01
First Post:
2015-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-28
First Submit QC Date:
None
Study First Post Date:
2015-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-11
Results First Submit QC Date:
None
Results First Post Date:
2016-08-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-26
Last Update Post Date:
2017-08-01
Last Update Post Date Type:
ACTUAL